I would like to begin by officially thanking all the Ministers, Deputy Ministers, Senior Government Officials, the South African Embassy and all our counterparts for making this short visit a great success. The past three days have been very busy with the …
SCOTTSDALE, Ariz., March 19, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug …
MIDLAND, Texas, March 19, 2025 (GLOBE NEWSWIRE) -- Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release first quarter 2025 financial results on May 5, 2025 after the market closes. In connection with the …
SPRINGFIELD, Mo., March 19, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Great Southern Bancorp, Inc. (NASDAQ:GSBC), the holding company for Great Southern Bank, declared a $0.40 per common share dividend for the first quarter of the calendar year …
MIDLAND, Texas, March 19, 2025 (GLOBE NEWSWIRE) -- Viper Energy, Inc. (NASDAQ: VNOM) (“Viper”), a subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release first quarter 2025 financial results on May 5, …
scPharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 million Cash and cash equivalents of $75.7 million as of December 31, 2024 U.S. Food and Drug Administration (FDA) approved the …
– Total Revenues increased 30.8% for the quarter over the prior year period to $51.7 million – – Total Written Premium increased 20.0% for the quarter over the prior year period to $361.4 million – – Organic Revenue Growth Rate* of 20.5% for the quarter – …
SOUTH SAN FRANCISCO, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and …
Preclinical pipeline re-prioritization to focus on four potentially transformative programs to advance toward clinic, led by CNTY-308 in B-cell mediated autoimmune diseases and malignancies New concentrated clinical focus for CNTY-101 based on unique …
Net Sales Increase of 7.8% for Q4 and 10.4% for Fiscal 2024 ex the 53rd week GAAP Diluted EPS of $3.39 for Q4 and $4.60 for Fiscal 2024 Adjusted Diluted EPS of $3.48 for Q4 and $5.04 for Fiscal 2024 PHILADELPHIA, PA, March 19, 2025 (GLOBE NEWSWIRE) -- Five …
NASHUA, N.H., March 19, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health …
BOSTON, March 19, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced it has …
CAMBRIDGE, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (“Akebia”) (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it has commenced an …
WASHINGTON, DC, UNITED STATES, March 19, 2025 /EINPresswire.com/ -- The Data Foundation today released its first "Evidence Capacity Pulse Report" documenting substantial changes affecting America's data and evaluation infrastructure …
Publishing Innovator Highlights the Power of Storytelling and Connection BEVERLY HILLS, CA, UNITED STATES, March 19, 2025 /EINPresswire.com/ -- Andréa Albright, Founder and CEO of Beverly Hills Publishing™, has been featured on the cover of …
Métis Crossing Knowledge Holder recognized for exceptional service and commitment to sharing Métis culture SMOKY LAKE, ALBERTA, CANADA, March 19, 2025 /EINPresswire.com/ -- Métis Crossing is proud to celebrate Lilyrose Meyers, the recipient of …
Daix (France), New York City (New York, United States), March 19, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for …
Daix (France), New York City (New York, Etats-Unis), le 19 mars 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par …
NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“ …
NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against AppLovin Corporation (“AppLovin” or “the …
02 days 11:33:49
